Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher D Porada

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Stem Cells (Dayton, Ohio)|September 5, 2014
Sheep CD34+ amniotic fluid cells have hematopoietic potential and engraft after autologous in utero transplantationS W Steven Shaw, Michael P Blundell, Caterina Pipino, et al.
Frontiers in Immunology|January 23, 2026
Transplanted gene-modified placental cells boost FVIII activity in pediatric sheep without eliciting immunity, toxicity, or adverse eventsBrady Trevisan, Martin Rodriguez, Ritu Ramamurthy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 18, 2020
Fetal and Maternal Safety Considerations for In Utero Therapy Clinical Trials: iFeTiS Consensus StatementRachel Sagar, Graça Almeida-Porada, Karin Blakemore, et al.
Nature Communications|July 14, 2023
Transplanting FVIII/ET3-secreting cells in fetal sheep increases FVIII levels long-term without inducing immunity or toxicityMartin Rodriguez, Brady Trevisan, Ritu M Ramamurthy, et al.
Molecular Therapy. Advances|July 6, 2026
Defining the safety and efficacy of liver-directed AAV gene therapy using a human liver tissue-equivalent platformRitu M Ramamurthy, Wen Ting Zheng, Sarah E Wachtman, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Stem Cells (Dayton, Ohio)|September 5, 2014
Sheep CD34+ amniotic fluid cells have hematopoietic potential and engraft after autologous in utero transplantationS W Steven Shaw, Michael P Blundell, Caterina Pipino, et al.
Frontiers in Immunology|January 23, 2026
Transplanted gene-modified placental cells boost FVIII activity in pediatric sheep without eliciting immunity, toxicity, or adverse eventsBrady Trevisan, Martin Rodriguez, Ritu Ramamurthy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 18, 2020
Fetal and Maternal Safety Considerations for In Utero Therapy Clinical Trials: iFeTiS Consensus StatementRachel Sagar, Graça Almeida-Porada, Karin Blakemore, et al.
Nature Communications|July 14, 2023
Transplanting FVIII/ET3-secreting cells in fetal sheep increases FVIII levels long-term without inducing immunity or toxicityMartin Rodriguez, Brady Trevisan, Ritu M Ramamurthy, et al.
Molecular Therapy. Advances|July 6, 2026
Defining the safety and efficacy of liver-directed AAV gene therapy using a human liver tissue-equivalent platformRitu M Ramamurthy, Wen Ting Zheng, Sarah E Wachtman, et al.
Pageof 8